{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:21:29Z","timestamp":1790144489369,"version":"4.0.1"},"reference-count":142,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychiatric Clinics of North America"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1016\/j.psc.2009.05.005","type":"journal-article","created":{"date-parts":[[2009,8,29]],"date-time":"2009-08-29T09:47:42Z","timestamp":1251539262000},"page":"593-610","source":"Crossref","is-referenced-by-count":64,"title":["Empirically Supported Treatments for Panic Disorder"],"prefix":"10.1016","volume":"32","author":[{"given":"R. Kathryn","family":"McHugh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasper A.J.","family":"Smits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"Otto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1\u20133","key":"10.1016\/j.psc.2009.05.005_bib1","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jad.2006.03.006","article-title":"Quality of life in early phases of panic disorder: predictive factors","volume":"94","author":"Carrera","year":"2006","journal-title":"J Affect Disord"},{"issue":"3","key":"10.1016\/j.psc.2009.05.005_bib2","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/01.nmd.0000154836.22687.13","article-title":"Quality of life and anxiety disorders: a population study","volume":"193","author":"Cramer","year":"2005","journal-title":"J Nerv Ment Dis"},{"key":"10.1016\/j.psc.2009.05.005_bib3","series-title":"Cost-effectiveness of psychotherapy: a guide for practitioners, researchers, and policymakers","article-title":"The costs of anxiety disorders: implications for psychosocial interventions","author":"Hofmann","year":"1999"},{"issue":"4","key":"10.1016\/j.psc.2009.05.005_bib4","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/da.20074","article-title":"The cost of treating anxiety: the medical and demographic correlates that impact total medical costs","volume":"21","author":"Marciniak","year":"2005","journal-title":"Depress Anxiety"},{"issue":"19","key":"10.1016\/j.psc.2009.05.005_bib5","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1001\/jama.283.19.2529","article-title":"Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: a randomized controlled trial","volume":"283","author":"Barlow","year":"2000","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.psc.2009.05.005_bib6","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1192\/bjp.164.6.759","article-title":"A comparison of cognitive therapy, applied relaxation and imipramine in the treatment of panic disorder","volume":"164","author":"Clark","year":"1994","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.psc.2009.05.005_bib7","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1192\/bjp.188.4.305","article-title":"Psychotherapy plus antidepressant for panic disorder with or without agoraphobia: systematic review","volume":"188","author":"Furukawa","year":"2006","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.psc.2009.05.005_bib8","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/0272-7358(95)00048-8","article-title":"A meta-analysis of treatment outcome for panic disorder","volume":"15","author":"Gould","year":"1995","journal-title":"Clin Psychol Rev"},{"key":"10.1016\/j.psc.2009.05.005_bib9","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1192\/bjp.162.6.776","article-title":"Alprazolam and exposure alone and combined in panic disorder with agoraphobia. A controlled study in London and Toronto","volume":"162","author":"Marks","year":"1993","journal-title":"Br J Psychiatry"},{"issue":"2","key":"10.1016\/j.psc.2009.05.005_bib10","first-page":"69","article-title":"Double-blind, placebo-controlled comparison of clonazepam and alprazolam for panic disorder","volume":"52","author":"Tesar","year":"1991","journal-title":"J Clin Psychiatry"},{"issue":"5","key":"10.1016\/j.psc.2009.05.005_bib11","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1001\/archpsyc.1988.01800290027004","article-title":"Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment","volume":"45","author":"Ballenger","year":"1988","journal-title":"Arch Gen Psychiatry"},{"issue":"9","key":"10.1016\/j.psc.2009.05.005_bib12","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/archpsyc.56.9.821","article-title":"Long-term maintenance and discontinuation of imipramine therapy in panic disorder with agoraphobia","volume":"56","author":"Mavissakalian","year":"1999","journal-title":"Arch Gen Psychiatry"},{"issue":"9","key":"10.1016\/j.psc.2009.05.005_bib13","doi-asserted-by":"crossref","first-page":"604","DOI":"10.4088\/JCP.v60n0907","article-title":"Efficacy, safety, and gradual discontinuation of clonazepam in panic disorder: a placebo-controlled, multicenter study using optimized dosages","volume":"60","author":"Moroz","year":"1999","journal-title":"J Clin Psychiatry"},{"issue":"8","key":"10.1016\/j.psc.2009.05.005_bib14","first-page":"349","article-title":"Diazepam versus alprazolam for the treatment of panic disorder","volume":"57","author":"Noyes","year":"1996","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"10.1016\/j.psc.2009.05.005_bib15","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/BF02244898","article-title":"MAO inhibitors in panic disorder: clinical effects of treatment with brofaromine. A double blind placebo controlled study","volume":"112","author":"van Vliet","year":"1993","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"10.1016\/j.psc.2009.05.005_bib16","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/msj.20041","article-title":"Anxiety disorders: a comprehensive review of pharmacotherapies","volume":"75","author":"Hoffman","year":"2008","journal-title":"Mt Sinai J Med"},{"issue":"2","key":"10.1016\/j.psc.2009.05.005_bib17","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00213-007-0821-0","article-title":"A randomized controlled trial of venlafaxine ER and paroxetine in the treatment of outpatients with panic disorder","volume":"194","author":"Pollack","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"issue":"12","key":"10.1016\/j.psc.2009.05.005_bib18","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1176\/appi.ajp.158.12.1989","article-title":"An effect-size analysis of the relative efficacy and tolerability of serotonin selective reuptake inhibitors for panic disorder","volume":"158","author":"Otto","year":"2001","journal-title":"Am J Psychiatry"},{"issue":"3","key":"10.1016\/j.psc.2009.05.005_bib19","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1034\/j.1600-0447.2002.02255.x","article-title":"SSRIs vs. TCAs in the treatment of panic disorder: a meta-analysis","volume":"106","author":"Bakker","year":"2002","journal-title":"Acta Psychiatr Scand"},{"issue":"6","key":"10.1016\/j.psc.2009.05.005_bib20","doi-asserted-by":"crossref","first-page":"654","DOI":"10.4088\/JCP.v64n0606","article-title":"Sertraline versus imipramine treatment of comorbid panic disorder and major depressive disorder","volume":"64","author":"Lepola","year":"2003","journal-title":"J Clin Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.psc.2009.05.005_bib21","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jad.2005.07.007","article-title":"The effect of pharmacotherapy on personality disorders in panic disorder: a one year naturalistic study","volume":"89","author":"Marchesi","year":"2005","journal-title":"J Affect Disord"},{"issue":"2","key":"10.1016\/j.psc.2009.05.005_bib22","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1055\/s-2006-931543","article-title":"Predictors of symptom resolution in panic disorder after one year of pharmacological treatment: a naturalistic study","volume":"39","author":"Marchesi","year":"2006","journal-title":"Pharmacopsychiatry"},{"issue":"4","key":"10.1016\/j.psc.2009.05.005_bib23","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/0010-440X(87)90072-1","article-title":"DSM-III personality disorder in agoraphobia. II. Changes with treatment","volume":"28","author":"Mavissakalian","year":"1987","journal-title":"Compr Psychiatry"},{"issue":"4","key":"10.1016\/j.psc.2009.05.005_bib24","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00004714-199308000-00005","article-title":"Long-term outcome after acute treatment with alprazolam or clonazepam for panic disorder","volume":"13","author":"Pollack","year":"1993","journal-title":"J Clin Psychopharmacol"},{"issue":"3","key":"10.1016\/j.psc.2009.05.005_bib25","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000285045","article-title":"Predictors and outcome in panic disorder: a 2-year prospective follow-up study","volume":"30","author":"Scheibe","year":"1997","journal-title":"Psychopathology"},{"issue":"4","key":"10.1016\/j.psc.2009.05.005_bib26","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0165-0327(94)90134-1","article-title":"Anxiety psychopathology predictive of outcome in patients with panic disorder and depression treated with imipramine, alprazolam and placebo","volume":"30","author":"Pollack","year":"1994","journal-title":"J Affect Disord"},{"issue":"9","key":"10.1016\/j.psc.2009.05.005_bib27","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1001\/archpsyc.1990.01810210017003","article-title":"Outcome of panic disorder. Relationship to diagnostic subtypes and comorbidity","volume":"47","author":"Noyes","year":"1990","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"10.1016\/j.psc.2009.05.005_bib28","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/da.1053","article-title":"The prediction of nonresponse to pharmacotherapy in panic disorder: a review","volume":"14","author":"Slaap","year":"2001","journal-title":"Depress Anxiety"},{"issue":"3","key":"10.1016\/j.psc.2009.05.005_bib29","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0165-0327(02)00312-9","article-title":"Blood-injury related phobic avoidance as predictor of nonresponse to pharmacotherapy in panic disorder with agoraphobia","volume":"78","author":"Overbeek","year":"2004","journal-title":"J Affect Disord"},{"issue":"1\u20132","key":"10.1016\/j.psc.2009.05.005_bib30","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jad.2007.12.007","article-title":"Beta-adrenoceptor affinity as a biological predictor of treatment response to paroxetine in patients with acute panic disorder","volume":"110","author":"Lee","year":"2008","journal-title":"J Affect Disord"},{"issue":"6","key":"10.1016\/j.psc.2009.05.005_bib31","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/da.20329","article-title":"Novel treatment approaches for refractory anxiety disorders","volume":"25","author":"Pollack","year":"2008","journal-title":"Depress Anxiety"},{"issue":"3","key":"10.1016\/j.psc.2009.05.005_bib32","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1177\/02698811030173009","article-title":"Combined paroxetine and clonazepam treatment strategies compared to paroxetine monotherapy for panic disorder","volume":"17","author":"Pollack","year":"2003","journal-title":"J Psychopharmacol"},{"issue":"2","key":"10.1016\/j.psc.2009.05.005_bib33","first-page":"66","article-title":"Augmentation strategies with tricyclic or fluoxetine treatment in seven partially responsive panic disorder patients","volume":"55","author":"Tiffon","year":"1994","journal-title":"J\u00a0Clin Psychiatry"},{"issue":"2","key":"10.1016\/j.psc.2009.05.005_bib34","first-page":"78","article-title":"Sodium valproate and clonazepam for treatment-resistant panic disorder","volume":"17","author":"Ontiveros","year":"1992","journal-title":"J Psychiatry Neurosci"},{"issue":"7","key":"10.1016\/j.psc.2009.05.005_bib35","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1176\/ajp.155.7.992","article-title":"Gabapentin as a potential treatment for anxiety disorders","volume":"155","author":"Pollack","year":"1998","journal-title":"Am J Psychiatry"},{"issue":"8","key":"10.1016\/j.psc.2009.05.005_bib36","doi-asserted-by":"crossref","first-page":"656","DOI":"10.4088\/JCP.v62n0813d","article-title":"Tiagabine improves panic and agoraphobia in panic disorder patients","volume":"62","author":"Zwanzger","year":"2001","journal-title":"J Clin Psychiatry"},{"issue":"5","key":"10.1016\/j.psc.2009.05.005_bib37","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/00004714-200010000-00011","article-title":"Pindolol augmentation in patients with treatment-resistant panic disorder: a double-blind, placebo-controlled trial","volume":"20","author":"Hirschmann","year":"2000","journal-title":"J\u00a0Clin Psychopharmacol"},{"issue":"1","key":"10.1016\/j.psc.2009.05.005_bib38","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/01.jcp.0000195108.01898.17","article-title":"Olanzapine augmentation in treatment-resistant panic disorder: a 12-week, fixed-dose, open-label trial","volume":"26","author":"Sepede","year":"2006","journal-title":"J Clin Psychopharmacol"},{"issue":"5","key":"10.1016\/j.psc.2009.05.005_bib39","doi-asserted-by":"crossref","first-page":"325","DOI":"10.4088\/JCP.v62n0503","article-title":"Sertraline treatment of posttraumatic stress disorder: results of 24 weeks of open-label continuation treatment","volume":"62","author":"Londborg","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.psc.2009.05.005_bib40","unstructured":"Workgroup on Panic Disorder. Practice guideline for the treatment of patients with panic disorder, second edition. Am J Psychiatry 2009;166(1)Suppl:1\u201348."},{"issue":"1","key":"10.1016\/j.psc.2009.05.005_bib41","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1037\/0033-295X.108.1.4","article-title":"A modern learning theory perspective on the etiology of panic disorder","volume":"108","author":"Bouton","year":"2001","journal-title":"Psychol Rev"},{"issue":"10","key":"10.1016\/j.psc.2009.05.005_bib42","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/S0006-3223(02)01475-0","article-title":"Anxiety sensitivity and panic disorder","volume":"52","author":"McNally","year":"2002","journal-title":"Biol Psychiatry"},{"issue":"Suppl 5","key":"10.1016\/j.psc.2009.05.005_bib43","first-page":"34","article-title":"Cognitive-behavioral therapy for the treatment of anxiety disorders","volume":"65","author":"Otto","year":"2004","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"10.1016\/j.psc.2009.05.005_bib44","doi-asserted-by":"crossref","first-page":"621","DOI":"10.4088\/JCP.v69n0415","article-title":"Cognitive-behavioral therapy for adult anxiety disorders: a meta-analysis of randomized placebo-controlled trials","volume":"69","author":"Hofmann","year":"2008","journal-title":"J Clin Psychiatry"},{"issue":"10","key":"10.1016\/j.psc.2009.05.005_bib45","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.brat.2003.07.004","article-title":"Cognitive behavior therapy vs exposure in vivo in the treatment of panic disorder with agoraphobia (corrected from agrophobia)","volume":"42","author":"Ost","year":"2004","journal-title":"Behav Res Ther"},{"issue":"7\u20138","key":"10.1016\/j.psc.2009.05.005_bib46","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0005-7967(98)00035-7","article-title":"Rate of improvement during cognitive-behavioral group treatment for panic disorder","volume":"36","author":"Penava","year":"1998","journal-title":"Behav Res Ther"},{"key":"10.1016\/j.psc.2009.05.005_bib47","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0005-7894(05)80367-3","article-title":"Behavioral treatment of panic: a two year follow-up","volume":"22","author":"Craske","year":"1991","journal-title":"Behav Ther"},{"issue":"1","key":"10.1016\/j.psc.2009.05.005_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0005-7967(93)90036-T","article-title":"Psychological treatment of panic: work in progress on outcome, active ingredients, and follow-up","volume":"31","author":"Margraf","year":"1993","journal-title":"Behav Res Ther"},{"issue":"5","key":"10.1016\/j.psc.2009.05.005_bib49","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1037\/0022-006X.63.5.823","article-title":"Impact of cognitive-behavioral treatment on quality of life in panic disorder patients","volume":"63","author":"Telch","year":"1995","journal-title":"J Consult Clin Psychol"},{"issue":"4","key":"10.1016\/j.psc.2009.05.005_bib50","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0887-6185(98)00020-6","article-title":"The effects of cognitive-behavior therapy for panic disorder on comorbid conditions","volume":"12","author":"Tsao","year":"1998","journal-title":"J Anxiety Disord"},{"issue":"7","key":"10.1016\/j.psc.2009.05.005_bib51","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.4088\/JCP.v68n0710","article-title":"Cost-efficacy of individual and combined treatments for panic disorder","volume":"68","author":"McHugh","year":"2007","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"10.1016\/j.psc.2009.05.005_bib52","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1037\/0022-006X.68.4.556","article-title":"Empirically supported treatments for panic disorder: costs, benefits, and stepped care","volume":"68","author":"Otto","year":"2000","journal-title":"J Consult Clin Psychol"},{"issue":"3","key":"10.1016\/j.psc.2009.05.005_bib53","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0005-7967(93)90026-Q","article-title":"Group cognitive-behavioral treatment of panic disorder","volume":"31","author":"Telch","year":"1993","journal-title":"Behav Res Ther"},{"issue":"3","key":"10.1016\/j.psc.2009.05.005_bib54","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000091776","article-title":"Quality of life and treatment outcome in panic disorder: cognitive behavior group therapy effects in patients refractory to medication treatment","volume":"75","author":"Heldt","year":"2006","journal-title":"Psychother Psychosom"},{"issue":"9","key":"10.1016\/j.psc.2009.05.005_bib55","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0005-7967(97)00038-7","article-title":"Does concurrent drug intake affect the long-term outcome of group cognitive behaviour therapy in panic disorder with or without agoraphobia?","volume":"35","author":"Oei","year":"1997","journal-title":"Behav Res Ther"},{"issue":"4","key":"10.1016\/j.psc.2009.05.005_bib56","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1037\/0022-006X.67.4.583","article-title":"Brief cognitive therapy for panic disorder: a randomized controlled trial","volume":"67","author":"Clark","year":"1999","journal-title":"J Consult Clin Psychol"},{"issue":"2","key":"10.1016\/j.psc.2009.05.005_bib57","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0005-7916(95)00003-I","article-title":"Brief cognitive-behavioral versus nondirective therapy for panic disorder","volume":"26","author":"Craske","year":"1995","journal-title":"J Behav Ther Exp Psychiatry"},{"issue":"1","key":"10.1016\/j.psc.2009.05.005_bib58","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/(SICI)1522-7154(1996)2:1<13::AID-ANXI2>3.0.CO;2-E","article-title":"Long-term course and outcome in panic disorder: a naturalistic follow-up study","volume":"2","author":"Cowley","year":"1996","journal-title":"Anxiety"},{"issue":"8","key":"10.1016\/j.psc.2009.05.005_bib59","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/00005053-199708000-00007","article-title":"Predictors of remission in patients with panic with and without agoraphobia: prospective 5-year follow-up data","volume":"185","author":"Warshaw","year":"1997","journal-title":"J\u00a0Nerv Ment Dis"},{"issue":"2","key":"10.1016\/j.psc.2009.05.005_bib60","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1037\/0022-006X.66.2.240","article-title":"Comorbid panic disorder and major depression: implications for cognitive-behavioral therapy","volume":"66","author":"McLean","year":"1998","journal-title":"J Consult Clin Psychol"},{"issue":"4","key":"10.1016\/j.psc.2009.05.005_bib61","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0005-7894(02)80013-2","article-title":"Effects of cognitive-behavioral therapy for panic disorder on comorbid conditions: replication and extension","volume":"33","author":"Tsao","year":"2002","journal-title":"Behav Ther"},{"issue":"6","key":"10.1016\/j.psc.2009.05.005_bib62","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.brat.2006.09.006","article-title":"Cognitive behavioral therapy for panic disorder and comorbidity: more of the same or less of more?","volume":"45","author":"Craske","year":"2007","journal-title":"Behav Res Ther"},{"issue":"2","key":"10.1016\/j.psc.2009.05.005_bib63","doi-asserted-by":"crossref","first-page":"247","DOI":"10.4088\/JCP.v67n0211","article-title":"Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions","volume":"67","author":"Conway","year":"2006","journal-title":"J Clin Psychiatry"},{"issue":"10","key":"10.1016\/j.psc.2009.05.005_bib64","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S0006-3223(02)01546-9","article-title":"Context, ambiguity, and unlearning: sources of relapse after behavioral extinction","volume":"52","author":"Bouton","year":"2002","journal-title":"Biol Psychiatry"},{"issue":"2","key":"10.1016\/j.psc.2009.05.005_bib65","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1037\/0022-006X.71.2.243","article-title":"Changes in caffeine states enhance return of fear in spider phobia","volume":"71","author":"Mystkowski","year":"2003","journal-title":"J Consult Clin Psychol"},{"issue":"3","key":"10.1016\/j.psc.2009.05.005_bib66","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1037\/0022-006X.76.3.478","article-title":"The effect of attributional processes concerning medication taking on return of fear","volume":"76","author":"Powers","year":"2008","journal-title":"J Consult Clin Psychol"},{"issue":"2","key":"10.1016\/j.psc.2009.05.005_bib67","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000068687","article-title":"Attribution of improvement to medication and increased risk of relapse of panic disorder with agoraphobia","volume":"72","author":"Biondi","year":"2003","journal-title":"Psychother Psychosom"},{"issue":"8","key":"10.1016\/j.psc.2009.05.005_bib68","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0005-7967(98)00176-4","article-title":"Group cognitive-behavior therapy for patients failing to respond to pharmacotherapy for panic disorder: a clinical case series","volume":"37","author":"Otto","year":"1999","journal-title":"Behav Res Ther"},{"issue":"5","key":"10.1016\/j.psc.2009.05.005_bib69","first-page":"200","article-title":"Cognitive behavior therapy for treatment-refractory panic disorder","volume":"55","author":"Pollack","year":"1994","journal-title":"J Clin Psychiatry"},{"issue":"5","key":"10.1016\/j.psc.2009.05.005_bib70","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.brat.2005.05.003","article-title":"One-year follow-up of pharmacotherapy-resistant patients with panic disorder treated with cognitive-behavior therapy: outcome and predictors of remission","volume":"44","author":"Heldt","year":"2006","journal-title":"Behav Res Ther"},{"issue":"1","key":"10.1016\/j.psc.2009.05.005_bib71","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000067188","article-title":"Treating medication-resistant panic disorder: predictors and outcome of cognitive-behavior therapy in a Brazilian public hospital","volume":"72","author":"Heldt","year":"2003","journal-title":"Psychother Psychosom"},{"issue":"10","key":"10.1016\/j.psc.2009.05.005_bib72","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1176\/ajp.150.10.1485","article-title":"Discontinuation of benzodiazepine treatment: efficacy of cognitive-behavioral therapy for patients with panic disorder","volume":"150","author":"Otto","year":"1993","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.psc.2009.05.005_bib73","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0005-7894(05)80282-5","article-title":"Combined cognitive-behavioral and time-limited alprazolam treatment of panic disorder","volume":"25","author":"Hegel","year":"1994","journal-title":"Behav Ther"},{"issue":"6","key":"10.1016\/j.psc.2009.05.005_bib74","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1176\/ajp.151.6.876","article-title":"Does cognitive behavior therapy assist slow-taper alprazolam discontinuation in panic disorder?","volume":"151","author":"Spiegel","year":"1994","journal-title":"Am J Psychiatry"},{"issue":"1","key":"10.1016\/j.psc.2009.05.005_bib75","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0005-7967(01)00003-1","article-title":"Antidepressant discontinuation in the context of cognitive behavioral treatment for panic disorder","volume":"40","author":"Schmidt","year":"2002","journal-title":"Behav Res Ther"},{"issue":"8","key":"10.1016\/j.psc.2009.05.005_bib76","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0005-7967(00)00067-X","article-title":"Cognitive-behavior therapy for discontinuation of SSRI treatment of panic disorder: a case series","volume":"39","author":"Whittal","year":"2001","journal-title":"Behav Res Ther"},{"key":"10.1016\/j.psc.2009.05.005_bib77","series-title":"Oxford handbook of anxiety and related disorders","article-title":"Pharmacotherapy for panic disorder and agoraphobia","author":"Pollack","year":"2009"},{"issue":"9540","key":"10.1016\/j.psc.2009.05.005_bib78","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0140-6736(06)69418-X","article-title":"Panic disorder","volume":"368","author":"Roy-Byrne","year":"2006","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.psc.2009.05.005_bib79","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.pscychresns.2003.10.004","article-title":"Reduced brain serotonin transporter binding in patients with panic disorder","volume":"132","author":"Maron","year":"2004","journal-title":"Psychiatry Res"},{"issue":"3","key":"10.1016\/j.psc.2009.05.005_bib80","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1192\/bjp.bp.107.041186","article-title":"Serotonin 5-HT1A receptor binding in people with panic disorder: positron emission tomography study","volume":"193","author":"Nash","year":"2008","journal-title":"Br J Psychiatry"},{"issue":"3","key":"10.1016\/j.psc.2009.05.005_bib81","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1017\/S1461145705005201","article-title":"Evidence-based pharmacotherapy of panic disorder","volume":"8","author":"Bakker","year":"2005","journal-title":"Int J Neuropsychopharmacol"},{"issue":"3","key":"10.1016\/j.psc.2009.05.005_bib82","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/sj.bjp.0702343","article-title":"Modulation of noradrenergic neuronal firing by selective serotonin reuptake blockers","volume":"126","author":"Szabo","year":"1999","journal-title":"Br J Pharmacol"},{"issue":"Suppl A","key":"10.1016\/j.psc.2009.05.005_bib83","first-page":"5","article-title":"Noradrenergic function in panic disorder","volume":"51","author":"Charney","year":"1990","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"10.1016\/j.psc.2009.05.005_bib84","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1177\/02698811030173002","article-title":"Does the brain noradrenaline network mediate the effects of the CO2 challenge?","volume":"17","author":"Bailey","year":"2003","journal-title":"J Psychopharmacol"},{"issue":"7","key":"10.1016\/j.psc.2009.05.005_bib85","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1001\/archpsyc.64.7.793","article-title":"Reduced gamma-aminobutyric acid(A)-benzodiazepine binding sites in insular cortex of individuals with panic disorder","volume":"64","author":"Cameron","year":"2007","journal-title":"Arch Gen Psychiatry"},{"issue":"10","key":"10.1016\/j.psc.2009.05.005_bib86","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1001\/archpsyc.65.10.1166","article-title":"Altered cerebral gamma-aminobutyric acid type A-benzodiazepine receptor binding in panic disorder determined by [11C]flumazenil positron emission tomography","volume":"65","author":"Hasler","year":"2008","journal-title":"Arch Gen Psychiatry"},{"issue":"6","key":"10.1016\/j.psc.2009.05.005_bib87","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1001\/archpsyc.58.6.556","article-title":"Reductions in occipital cortex GABA levels in panic disorder detected with 1h-magnetic resonance spectroscopy","volume":"58","author":"Goddard","year":"2001","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"10.1016\/j.psc.2009.05.005_bib88","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.pnpbp.2006.10.011","article-title":"Decreased GABA levels in anterior cingulate and basal ganglia in medicated subjects with panic disorder: a proton magnetic resonance spectroscopy (1H-MRS) study","volume":"31","author":"Ham","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"4","key":"10.1016\/j.psc.2009.05.005_bib89","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/0005-7967(86)90011-2","article-title":"A cognitive approach to panic","volume":"24","author":"Clark","year":"1986","journal-title":"Behav Res Ther"},{"key":"10.1016\/j.psc.2009.05.005_bib90","series-title":"Anxiety and its disorders: the nature and treatment of anxiety and panic","author":"Barlow","year":"2002"},{"issue":"4","key":"10.1016\/j.psc.2009.05.005_bib91","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1037\/0022-006X.72.4.646","article-title":"Mechanism of change in cognitive-behavioral treatment of panic disorder: evidence for the fear of fear mediational hypothesis","volume":"72","author":"Smits","year":"2004","journal-title":"J Consult Clin Psychol"},{"issue":"3","key":"10.1016\/j.psc.2009.05.005_bib92","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1037\/0022-006X.75.3.374","article-title":"Preliminary evidence for cognitive mediation during cognitive-behavioral therapy of panic disorder","volume":"75","author":"Hofmann","year":"2007","journal-title":"J Consult Clin Psychol"},{"key":"10.1016\/j.psc.2009.05.005_bib93","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0005-7894(98)80037-3","article-title":"Social phobia: effects of external attention on anxiety, negative beliefs, and perspective taking","volume":"29","author":"Wells","year":"1998","journal-title":"Behav Ther"},{"issue":"2","key":"10.1016\/j.psc.2009.05.005_bib94","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0005-7916(03)00037-5","article-title":"Emotional responding to hyperventilation as a predictor of agoraphobia status among individuals suffering from panic disorder","volume":"34","author":"Telch","year":"2003","journal-title":"J Behav Ther Exp Psychiatry"},{"issue":"6","key":"10.1016\/j.psc.2009.05.005_bib95","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0005-7967(98)00153-3","article-title":"An experimental investigation of the role of safety-seeking behaviours in the maintenance of panic disorder with agoraphobia","volume":"37","author":"Salkovskis","year":"1999","journal-title":"Behav Res Ther"},{"key":"10.1016\/j.psc.2009.05.005_bib96","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0005-7894(05)80088-7","article-title":"Social phobia: the role of in-situation safety behaviors in maintaining anxiety and negative beliefs","volume":"26","author":"Wells","year":"1995","journal-title":"Behav Ther"},{"issue":"3","key":"10.1016\/j.psc.2009.05.005_bib97","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1037\/0022-006X.68.3.417","article-title":"Dismantling cognitive-behavioral treatment for panic disorder: questioning the utility of breathing retraining","volume":"68","author":"Schmidt","year":"2000","journal-title":"J Consult Clin Psychol"},{"issue":"3","key":"10.1016\/j.psc.2009.05.005_bib98","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0005-7967(95)00077-1","article-title":"Exposure versus cognitive restructuring in the treatment of panic disorder with agoraphobia","volume":"34","author":"Bouchard","year":"1996","journal-title":"Behav Res Ther"},{"issue":"4","key":"10.1016\/j.psc.2009.05.005_bib99","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/0005-7967(94)90008-6","article-title":"Exposure reduced agoraphobia but not panic, and cognitive therapy reduced panic but not agoraphobia","volume":"32","author":"van den Hout","year":"1994","journal-title":"Behav Res Ther"},{"issue":"2","key":"10.1016\/j.psc.2009.05.005_bib100","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1037\/0022-006X.74.2.377","article-title":"Effectiveness of cognitive-behavioral treatment for panic disorder versus treatment as usual in a managed care setting: 2-year follow-up","volume":"74","author":"Addis","year":"2006","journal-title":"J Consult Clin Psychol"},{"issue":"5","key":"10.1016\/j.psc.2009.05.005_bib101","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1037\/0022-006X.63.5.754","article-title":"Long-term outcome in cognitive-behavioral treatment of panic disorder: clinical predictors and alternative strategies for assessment","volume":"63","author":"Brown","year":"1995","journal-title":"J\u00a0Consult Clin Psychol"},{"issue":"7","key":"10.1016\/j.psc.2009.05.005_bib102","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jpsychires.2007.06.005","article-title":"Feedback of end-tidal pCO2 as a therapeutic approach for panic disorder","volume":"42","author":"Meuret","year":"2008","journal-title":"J Psychiatr Res"},{"issue":"12","key":"10.1016\/j.psc.2009.05.005_bib103","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1176\/appi.ajp.158.12.1993","article-title":"Emotion-focused psychotherapy for patients with panic disorder","volume":"158","author":"Shear","year":"2001","journal-title":"Am J Psychiatry"},{"issue":"2","key":"10.1016\/j.psc.2009.05.005_bib104","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1176\/appi.ajp.164.2.265","article-title":"A randomized controlled trial of psychoanalytic psychotherapy for panic disorder","volume":"164","author":"Milrod","year":"2007","journal-title":"Am J Psychiatry"},{"issue":"6","key":"10.1016\/j.psc.2009.05.005_bib105","doi-asserted-by":"crossref","first-page":"885","DOI":"10.4088\/JCP.v68n0610","article-title":"Do comorbid personality disorders moderate panic-focused psychotherapy? An exploratory examination of the American Psychiatric Association practice guideline","volume":"68","author":"Milrod","year":"2007","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"10.1016\/j.psc.2009.05.005_bib106","first-page":"179","article-title":"Exercise interventions for mental health: a quantitative and qualitative review","volume":"13","author":"Stathopoulou","year":"2006","journal-title":"Br J Clin Psychol"},{"issue":"2","key":"10.1016\/j.psc.2009.05.005_bib107","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0005-7967(03)00103-7","article-title":"Effects of aerobic exercise on anxiety sensitivity","volume":"42","author":"Broman-Fulks","year":"2004","journal-title":"Behav Res Ther"},{"issue":"2","key":"10.1016\/j.psc.2009.05.005_bib108","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/10615800701762675","article-title":"Evaluation of a brief aerobic exercise intervention for high anxiety sensitivity","volume":"21","author":"Broman-Fulks","year":"2008","journal-title":"Anxiety Stress Coping"},{"issue":"8","key":"10.1016\/j.psc.2009.05.005_bib109","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/da.20411","article-title":"Reducing anxiety sensitivity with exercise","volume":"25","author":"Smits","year":"2008","journal-title":"Depress Anxiety"},{"issue":"5","key":"10.1016\/j.psc.2009.05.005_bib110","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1176\/ajp.155.5.603","article-title":"Comparison of aerobic exercise, clomipramine, and placebo in the treatment of panic disorder","volume":"155","author":"Broocks","year":"1998","journal-title":"Am J Psychiatry"},{"issue":"10","key":"10.1016\/j.psc.2009.05.005_bib111","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1001\/archpsyc.61.10.1005","article-title":"Fluoxetine, comprehensive cognitive behavioral therapy, and placebo in generalized social phobia","volume":"61","author":"Davidson","year":"2004","journal-title":"Arch Gen Psychiatry"},{"issue":"5","key":"10.1016\/j.psc.2009.05.005_bib112","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1101\/lm.78204","article-title":"Facilitation of fear extinction by D-cycloserine: theoretical and clinical implications","volume":"11","author":"Richardson","year":"2004","journal-title":"Learn Mem"},{"issue":"11","key":"10.1016\/j.psc.2009.05.005_bib113","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1001\/archpsyc.61.11.1136","article-title":"Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear","volume":"61","author":"Ressler","year":"2004","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"10.1016\/j.psc.2009.05.005_bib114","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1001\/archpsyc.63.3.298","article-title":"Augmentation of exposure therapy with D-cycloserine for social anxiety disorder","volume":"63","author":"Hofmann","year":"2006","journal-title":"Arch Gen Psychiatry"},{"issue":"6","key":"10.1016\/j.psc.2009.05.005_bib115","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.biopsych.2007.11.011","article-title":"A randomized controlled trial of D-cycloserine enhancement of exposure therapy for social anxiety disorder","volume":"63","author":"Guastella","year":"2008","journal-title":"Biol Psychiatry"},{"issue":"8","key":"10.1016\/j.psc.2009.05.005_bib116","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.biopsych.2006.12.020","article-title":"D-cycloserine augmented exposure therapy for obsessive-compulsive disorder","volume":"62","author":"Kushner","year":"2007","journal-title":"Biol Psychiatry"},{"issue":"12","key":"10.1016\/j.psc.2009.05.005_bib117","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.biopsych.2008.01.012","article-title":"A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy","volume":"63","author":"Norberg","year":"2008","journal-title":"Biol Psychiatry"},{"issue":"8","key":"10.1016\/j.psc.2009.05.005_bib118","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1080\/j.1440-1614.2004.01423.x","article-title":"Cost-effectiveness of psychological and pharmacological interventions for generalized anxiety disorder and panic disorder","volume":"38","author":"Heuzenroeder","year":"2004","journal-title":"Aust N Z J Psychiatry"},{"issue":"11","key":"10.1016\/j.psc.2009.05.005_bib119","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1017\/S003329170500557X","article-title":"Does the addition of cognitive behavioral therapy improve panic disorder treatment outcome relative to medication alone in the primary-care setting?","volume":"35","author":"Craske","year":"2005","journal-title":"Psychol Med"},{"issue":"3","key":"10.1016\/j.psc.2009.05.005_bib120","first-page":"117","article-title":"Agoraphobia: relative and combined effectiveness of therapist-assisted in vivo exposure and imipramine","volume":"47","author":"Mavissakalian","year":"1986","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"10.1016\/j.psc.2009.05.005_bib121","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0005-7967(85)90011-7","article-title":"Combined pharmacological and behavioral treatment for agoraphobia","volume":"23","author":"Telch","year":"1985","journal-title":"Behav Res Ther"},{"issue":"4","key":"10.1016\/j.psc.2009.05.005_bib122","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1037\/0022-006X.72.4.625","article-title":"Effectiveness of cognitive\u2013behavioral treatment for panic disorder versus treatment as usual in a managed care setting","volume":"72","author":"Addis","year":"2004","journal-title":"J Consult Clin Psychol"},{"issue":"3","key":"10.1016\/j.psc.2009.05.005_bib123","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1037\/0022-006X.68.3.506","article-title":"Effectiveness of an empirically based treatment for panic disorder delivered in a service clinic setting: 1-year follow-up","volume":"68","author":"Stuart","year":"2000","journal-title":"J\u00a0Consult Clin Psychol"},{"issue":"2","key":"10.1016\/j.psc.2009.05.005_bib124","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1037\/0022-006X.66.2.231","article-title":"Transporting an empirically supported treatment for panic disorder to a service clinic setting: a benchmarking strategy","volume":"66","author":"Wade","year":"1998","journal-title":"J Consult Clin Psychol"},{"issue":"11","key":"10.1016\/j.psc.2009.05.005_bib126","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1176\/ajp.156.11.1819","article-title":"Psychosocial treatment prescriptions for generalized anxiety disorder, panic disorder, and social phobia, 1991-1996","volume":"156","author":"Goisman","year":"1999","journal-title":"Am J Psychiatry"},{"issue":"12","key":"10.1016\/j.psc.2009.05.005_bib127","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1176\/appi.ajp.161.12.2230","article-title":"Quality of care for primary care patients with anxiety disorders","volume":"161","author":"Stein","year":"2004","journal-title":"Am J Psychiatry"},{"issue":"3","key":"10.1016\/j.psc.2009.05.005_bib128","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1001\/archpsyc.62.3.290","article-title":"A randomized effectiveness trial of cognitive-behavioral therapy and medication for primary care panic disorder","volume":"62","author":"Roy-Byrne","year":"2005","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"10.1016\/j.psc.2009.05.005_bib129","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1017\/S0033291705006896","article-title":"Incremental cost-effectiveness of a collaborative care intervention for panic disorder","volume":"36","author":"Katon","year":"2006","journal-title":"Psychol Med"},{"key":"10.1016\/j.psc.2009.05.005_bib130","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1192\/bjp.179.5.456","article-title":"Reducing demands on clinicians by offering computer-aided self-help for phobia\/panic. Feasibility study","volume":"179","author":"Kenwright","year":"2001","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.psc.2009.05.005_bib131","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1192\/bjp.184.5.448","article-title":"Computer-aided self-help for phobia\/panic via internet at home: a pilot study","volume":"184","author":"Kenwright","year":"2004","journal-title":"Br J Psychiatry"},{"issue":"3","key":"10.1016\/j.psc.2009.05.005_bib132","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000084000","article-title":"Internet-guided self-help with or without exposure therapy for phobic and panic disorders","volume":"74","author":"Schneider","year":"2005","journal-title":"Psychother Psychosom"},{"issue":"5","key":"10.1016\/j.psc.2009.05.005_bib133","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.genhosppsych.2007.04.005","article-title":"Design of the Coordinated Anxiety Learning and Management (CALM) study: innovations in collaborative care for anxiety disorders","volume":"29","author":"Sullivan","year":"2007","journal-title":"Gen Hosp Psychiatry"},{"issue":"8","key":"10.1016\/j.psc.2009.05.005_bib134","first-page":"1187","article-title":"The effects of clonazepam on quality of life and work productivity in panic disorder","volume":"3","author":"Jacobs","year":"1997","journal-title":"Am J Manag Care"},{"issue":"6","key":"10.1016\/j.psc.2009.05.005_bib135","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1176\/appi.ajp.157.6.1014","article-title":"Is placebo response the same as drug response in panic disorder?","volume":"157","author":"Rapaport","year":"2000","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.psc.2009.05.005_bib136","series-title":"Diagnostic and statistical manual of mental disorders","year":"1994"},{"issue":"3","key":"10.1016\/j.psc.2009.05.005_bib137","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000116608","article-title":"Agoraphobia and panic. Prospective-longitudinal relations suggest a rethinking of diagnostic concepts","volume":"77","author":"Wittchen","year":"2008","journal-title":"Psychother Psychosom"},{"issue":"12","key":"10.1016\/j.psc.2009.05.005_bib138","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1176\/ajp.145.12.1564","article-title":"Prodromal symptoms in panic disorder with agoraphobia","volume":"145","author":"Fava","year":"1988","journal-title":"Am J Psychiatry"},{"issue":"2","key":"10.1016\/j.psc.2009.05.005_bib139","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0165-0327(92)90038-8","article-title":"Prodromal symptoms in panic disorder with agoraphobia: a replication study","volume":"26","author":"Fava","year":"1992","journal-title":"J Affect Disord"},{"issue":"4","key":"10.1016\/j.psc.2009.05.005_bib140","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1001\/archpsyc.63.4.415","article-title":"The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication","volume":"63","author":"Kessler","year":"2006","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"10.1016\/j.psc.2009.05.005_bib141","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1037\/0021-843X.114.4.491","article-title":"Introduction to the special section: toward a dimensionally based taxonomy of psychopathology","volume":"114","author":"Krueger","year":"2005","journal-title":"J Abnorm Psychol"},{"issue":"4","key":"10.1016\/j.psc.2009.05.005_bib142","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1037\/0021-843X.114.4.522","article-title":"Rethinking the mood and anxiety disorders: a quantitative hierarchical model for DSM-V","volume":"114","author":"Watson","year":"2005","journal-title":"J Abnorm Psychol"},{"issue":"2","key":"10.1016\/j.psc.2009.05.005_bib143","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1177\/0145445506297015","article-title":"Anxiety sensitivity: a missing piece to the agoraphobia-without-panic puzzle","volume":"31","author":"Hayward","year":"2007","journal-title":"Behav Modif"}],"container-title":["Psychiatric Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0193953X09000513?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0193953X09000513?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T14:48:21Z","timestamp":1685112501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0193953X09000513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":142,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S0193953X09000513"],"URL":"https:\/\/doi.org\/10.1016\/j.psc.2009.05.005","relation":{},"ISSN":["0193-953X"],"issn-type":[{"value":"0193-953X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}